AKT1 and diffuse large B-cell lymphoma: Interestingly, the bicluster targets in both cancer types were strongly enriched with ‘PI3K/Akt signaling pathway’ (FDR = 2.6E-7 for breast cancer; FDR = 5.3E-7 for DLBCL).